Published in Adv Biochem Psychopharmacol on January 01, 1982
Tranylcypromine: new perspectives on an "old" drug. Eur Arch Psychiatry Clin Neurosci (2006) 0.93
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatry Neurosci (1992) 0.91
Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) (1995) 3.61
Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) (1999) 1.76
Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol (1997) 1.65
Murine models of depression. Psychopharmacology (Berl) (1999) 1.64
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl) (1997) 1.49
Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology (2000) 1.48
Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res (1996) 1.43
Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci (1999) 1.42
Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology (1998) 1.33
Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci U S A (2000) 1.29
Psychomotor performance following the long-term use of benzodiazepines. Psychopharmacol Bull (1985) 1.23
Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology (Berl) (2001) 1.23
Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci (2001) 1.22
Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther (1997) 1.21
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther (2000) 1.20
Intracellular lithium concentration and clinical response: towards a membrane theory of depression. J Psychiatr Res (1973) 1.19
Behavioral analysis of CREB alphadelta mutation on a B6/129 F1 hybrid background. Hippocampus (2002) 1.19
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther (2000) 1.18
The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res (1997) 1.16
Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther (1984) 1.15
Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res (1995) 1.13
Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther (2001) 1.10
Control rate of response or reinforcement and amphetamine's effect on behavior. J Exp Anal Behav (1983) 1.10
Same-day X-ray reporting is not needed in well-supervised emergency departments. Emerg Med (Fremantle) (2001) 1.08
Prenatal stress induces long term stress vulnerability, compromising stress response systems in the brain and impairing extinction of conditioned fear after adult stress. Neuroscience (2011) 1.07
Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther (1984) 1.06
Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun (1987) 1.05
Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther (1994) 1.05
A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology (1991) 1.04
Early life protein restriction alters dopamine circuitry. Neuroscience (2010) 1.04
Apomorphine: effect on growth hormone. J Clin Endocrinol Metab (1975) 1.03
The prediction of brain lithium concentrations from plasma or erythrocyte measures. J Psychiatr Res (1973) 1.03
Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures. Endocrinology (1996) 1.01
Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther (1995) 1.01
Genetic determinant of lithium ion distribution. I. An in vitro monozygotic-dizygotic twin study. Arch Gen Psychiatry (1974) 1.00
5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J Neurochem (2000) 1.00
Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology (Berl) (1986) 0.99
Amine precursors and depression. Arch Gen Psychiatry (1975) 0.99
The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain. Neuropharmacology (1980) 0.97
Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs. Depress Anxiety (1997) 0.97
Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers. Am J Geriatr Psychiatry (2001) 0.96
Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) (1998) 0.94
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. J Clin Psychopharmacol (2000) 0.94
Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. Br J Clin Pharmacol (1987) 0.94
Serotonergic involvement in haloperidol-induced catalepsy. J Pharmacol Exp Ther (1993) 0.94
Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther (2001) 0.93
Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology (Berl) (1990) 0.93
The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med (1987) 0.93
Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors. J Pharmacol Exp Ther (2000) 0.92
Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology (Berl) (1995) 0.92
Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. J Pharmacol Exp Ther (2001) 0.92
Brain biogenic amine depletion and mood. Arch Gen Psychiatry (1974) 0.92
[3H]nisoxetine: a new radioligand for norepinephrine uptake sites in brain. Eur J Pharmacol (1990) 0.92
Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry (1985) 0.91
The effect of repeated exposure to forced swimming on extracellular levels of 5-hydroxytryptamine in the rat. Stress (1998) 0.91
Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. J Pharmacol Exp Ther (2000) 0.91
In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther (1998) 0.91
Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei. Synapse (1997) 0.91
Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus. Synapse (1994) 0.91
Erythrocyte concentrations of the lithium ion: clinical correlates and mechanisms of action. Am J Psychiatry (1978) 0.91
Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats. Brain Res (1988) 0.90
A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia. Neuroscience (1996) 0.90
Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol. J Pharmacol Exp Ther (1988) 0.90
[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med (1997) 0.89
The effects of thyroxine on rat heart adenosine 3',5'-monophosphate, phosphorylase b kinase and phosphorylase a activity. J Pharmacol Exp Ther (1969) 0.89
Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress. Biol Psychiatry (2001) 0.89
Reduced central serotonergic activity in mania: implications for the relationship between depression and mania. Br J Psychiatry (1975) 0.88
IPT: a novel iodinated ligand for the CNS dopamine transporter. Synapse (1995) 0.88
5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test. Eur J Pharmacol (2000) 0.88
Alterations in cell membrane activity in depression. Am J Psychiatry (1974) 0.87
Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters. J Pharmacol Exp Ther (1997) 0.87
Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. J Pharmacol Exp Ther (2001) 0.87
Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine. Brain Res (1988) 0.87
Effect of repeated administration of novel stressors on central beta adrenoceptors. J Neural Transm Gen Sect (1991) 0.86
Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat. J Pharmacol Exp Ther (1988) 0.86
The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience (1993) 0.85
Rate-dependent effects of amphetamine on responding under random-interval schedules of reinforcement in the rat. Pharmacol Biochem Behav (1983) 0.85
Lithium efflux from erythrocytes incubated in vitro during lithium carbonate administration. Commun Psychopharmacol (1978) 0.85
A method for the determination of sodium, potassium, magnesium and lithium concentrations in erythrocytes. Clin Chim Acta (1972) 0.85
Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT. Neuropharmacology (1992) 0.85
Can the effects of antidepressants be observed in the first two weeks of treatment? Neuropsychopharmacology (1997) 0.85
Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther (1989) 0.85
Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patients. Acta Psychiatr Scand (1987) 0.84
Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. N Engl J Med (1986) 0.83
Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology (1994) 0.83
Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology (Berl) (2001) 0.83
Amish study, V: Lithium-sodium countertransport and catechol O-methyltransferase in pedigrees of bipolar probands. Am J Psychiatry (1984) 0.83
Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation. J Clin Psychopharmacol (1999) 0.83
Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology (Berl) (1993) 0.83
The effect of antidepressant drugs on regional cerebral glucose utilization in the rat. Brain Res (1983) 0.83
Growth hormone, prolactin and thyrotropin responses to gonadotropin-releasing hormone in depressed patients and healthy volunteers. Psychoneuroendocrinology (1982) 0.83
Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatr Scand (1983) 0.82
Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain. J Pharmacol Exp Ther (1980) 0.82
Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP. Life Sci (1985) 0.82
Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding. J Pharmacol Exp Ther (1993) 0.82
Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry (1983) 0.82
Dissociation of the increased formation of cardiac adenosine 3',5'-monophosphate from the positive inotropic effect of norepinephrine. J Pharmacol Exp Ther (1969) 0.82
Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients. Science (1972) 0.82